We are live on
!
Find out more
Vir Biotechnology
175 hedge funds and large institutions have $3.24B invested in Vir Biotechnology in 2021 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 65 increasing their positions, 45 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
90% more call options, than puts
Call options by funds: $27.1M | Put options by funds: $14.3M
44% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 45
42% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 26
6% more funds holding
Funds holding: 165 → 175 (+10)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
2.14% less ownership
Funds ownership: 59.16% → 57.02% (-2.1%)
11% less capital invested
Capital invested by funds: $3.64B → $3.24B (-$395M)
Holders
175
Holders Change
+10
Holders Change %
+6.06%
% of All Funds
3.06%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
37
Increased
65
Reduced
45
Closed
26
Calls
$27.1M
Puts
$14.3M
Net Calls
+$12.9M
Net Calls Change
+$4.15M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41.5M |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$20.6M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$15.3M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$8.91M |
| 5 |
BlackRock
New York
|
+$7.71M |
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$135M |
| 2 |
GF
Gates Foundation
Seattle,
Washington
|
-$90.9M |
| 3 |
PCM
Pathway Capital Management
Irvine,
California
|
-$22.3M |
| 4 |
APF
Alaska Permanent Fund
Juneau,
Alaska
|
-$9.85M |
| 5 |
Morgan Stanley
New York
|
-$8.43M |
